Hot Features
プレミアム
Nurix Therapeutics Inc (NRIX)
NASDAQ
登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。
| 日付 | 保有者名 | 取引株数 | 金額レンジ ($) | 取引種別 | 価格レンジ ($) | 届出終了時の株数 | % 変化 |
|---|---|---|---|---|---|---|---|
| 2026-05-05 | Mr. Johannes Van HouteCFO | -14.06k | 233.32k | Automatic Disposition | 16.58 - 17.18 | 37.59k | -27.21% |
| 2026-05-04 | Dr. Christine RingChief Legal Officer, Secretary & CCO | -8.15k | 138.21k | Automatic Disposition | 16.96 | 18.31k | -30.80% |
| 2026-05-01 | Dr. Christine RingChief Legal Officer, Secretary & CCO | -5.39k | 90.41k | Automatic Disposition | 16.76 | 26.45k | -16.94% |
| 2026-04-30 | Mr. Johannes Van HouteCFO | -2.39k | 39.75k | Derivative Exercise and Sale | 16.65 | 51.65k | - |
| 2026-04-30 | Mr. Johannes Van HouteCFO | 6.22k | 0.00 | Derivative Exercise and Retained Stock | - | 51.65k | 13.69% |
| 2026-04-30 | Dr. Christine RingChief Legal Officer, Secretary & CCO | -3.21k | 53.50k | Derivative Exercise and Sale | 16.65 | 31.85k | - |
| 2026-04-30 | Dr. Christine RingChief Legal Officer, Secretary & CCO | 5.39k | 0.00 | Derivative Exercise and Retained Stock | - | 31.85k | 20.39% |
| 2026-04-30 | Dr. Gwenn M. HansenChief Scientific Officer | -3.21k | 53.50k | Derivative Exercise and Sale | 16.65 | 120.40k | - |
| 2026-04-30 | Dr. Gwenn M. HansenChief Scientific Officer | 5.39k | 0.00 | Derivative Exercise and Retained Stock | - | 120.40k | 4.69% |
| 2026-04-02 | Dr. Christine RingChief Legal Officer, Secretary & CCO | -8.15k | 124.15k | Automatic Disposition | 15.24 | 26.45k | -23.55% |
| 2026-03-02 | Dr. Christine RingChief Legal Officer, Secretary & CCO | -8.15k | 125.79k | Automatic Disposition | 15.44 | 34.60k | -19.06% |
| 2026-02-09 | Dr. Christine RingChief Legal Officer, Secretary & CCO | -14.26k | 237.62k | Automatic Disposition | 16.66 | 42.75k | -25.01% |
| 2026-02-03 | Dr. Gwenn M. HansenChief Scientific Officer | 31.33k | 26.32k | Derivative Exercise and Retained Stock | 0.84 | 115.01k | 37.45% |
| 2026-01-30 | Mr. Johannes Van HouteCFO | 7.84k | 0.00 | Derivative Exercise and Retained Stock | - | 45.43k | 20.84% |
| 2026-01-30 | Mr. Johannes Van HouteCFO | -3.66k | 60.77k | Derivative Exercise and Sale | 16.58 - 17.37 | 45.43k | - |
| 2026-01-30 | Dr. Christine RingChief Legal Officer, Secretary & CCO | 6.11k | 0.00 | Derivative Exercise and Retained Stock | - | 57.01k | 12.01% |
| 2026-01-30 | Dr. Christine RingChief Legal Officer, Secretary & CCO | -4.42k | 73.38k | Derivative Exercise and Sale | 16.58 - 17.37 | 57.01k | - |
| 2026-01-30 | Dr. Gwenn M. HansenChief Scientific Officer | 6.92k | 0.00 | Derivative Exercise and Retained Stock | - | 83.67k | 9.02% |
| 2026-01-30 | Dr. Gwenn M. HansenChief Scientific Officer | -4.90k | 81.25k | Derivative Exercise and Sale | 16.58 - 17.37 | 83.67k | - |
| 2026-01-20 | Dr. Christine RingChief Legal Officer, Secretary & CCO | -3.76k | 62.28k | Derivative Exercise and Sale | 1.86 - 18.42 | 50.90k | - |
| 2025-12-18 | Dr. Christine RingChief Legal Officer, Secretary & CCO | -3.76k | 60.32k | Derivative Exercise and Sale | 1.86 - 18.56 | 50.90k | - |
| 2025-11-24 | Dr. Christine RingChief Legal Officer, Secretary & CCO | -37.60k | 571.76k | Derivative Exercise and Sale | 1.86 - 17.07 | 50.90k | - |
| 2025-11-03 | Mr. Johannes Van HouteCFO | -6.28k | 78.93k | Automatic Disposition | 12.56 | 37.59k | -14.32% |
| 2025-10-30 | Mr. Johannes Van HouteCFO | 8.36k | 0.00 | Derivative Exercise and Retained Stock | - | 43.88k | 23.55% |
| 2025-10-30 | Mr. Johannes Van HouteCFO | -3.13k | 40.05k | Derivative Exercise and Sale | 12.80 | 43.88k | - |
| 2025-10-30 | Dr. Christine RingChief Legal Officer, Secretary & CCO | 6.89k | 0.00 | Derivative Exercise and Retained Stock | - | 50.90k | 15.65% |
| 2025-10-30 | Dr. Christine RingChief Legal Officer, Secretary & CCO | -3.64k | 46.63k | Derivative Exercise and Sale | 12.80 | 50.90k | - |
| 2025-10-30 | Dr. Gwenn M. HansenChief Scientific Officer | 7.73k | 0.00 | Derivative Exercise and Retained Stock | - | 76.75k | 11.20% |
| 2025-10-30 | Dr. Gwenn M. HansenChief Scientific Officer | -4.09k | 52.30k | Derivative Exercise and Sale | 12.80 | 76.75k | - |
| 2025-09-17 | Ms. Julia Paige GregoryIndependent Chairman | 10.75k | 20.00k | Derivative Exercise and Retained Stock | 1.86 | 10.75k | - |
| 2025-08-01 | Mr. Johannes Van HouteCFO | -5.40k | 59.60k | Automatic Disposition | 11.03 | 35.51k | -13.20% |
| 2025-07-30 | Dr. Gwenn M. HansenChief Scientific Officer | 7.51k | 0.00 | Derivative Exercise and Retained Stock | - | 69.02k | 12.20% |
| 2025-07-30 | Dr. Gwenn M. HansenChief Scientific Officer | -4.31k | 51.74k | Derivative Exercise and Sale | 12.01 | 69.02k | - |
| 2025-07-30 | Dr. Christine RingChief Legal Officer, Secretary & CCO | 6.69k | 0.00 | Derivative Exercise and Retained Stock | - | 44.01k | 17.93% |
| 2025-07-30 | Dr. Christine RingChief Legal Officer, Secretary & CCO | -3.84k | 46.13k | Derivative Exercise and Sale | 12.01 | 44.01k | - |
| 2025-07-30 | Mr. Johannes Van HouteCFO | 7.19k | 0.00 | Derivative Exercise and Retained Stock | - | 40.91k | 21.32% |
| 2025-07-30 | Mr. Johannes Van HouteCFO | -4.30k | 51.70k | Derivative Exercise and Sale | 12.01 | 40.91k | - |
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約
メールアドレスで登録
すでにアカウントをお持ちですか？ サインイン
アカウントをお持ちでないですか？ 登録
登録することで、ADVFN の 利用規約 を読み、理解し、同意したこと、および私が個人投資家であることを確認します。
